CannLabs Inc. (OTC: CANL), a leading provider of proprietary, cloud-based analytics and scientific testing methodologies to the cannabis industry, was recently mentioned in a Congressional testimony by Congresswoman Dina Titus – a Democrat from Las Vegas, Nevada. The testimony comes after the company recently secured a license in the state to operate a cannabis testing laboratory.

While discussing how the cannabis industry has evolved from a “head shop with a picture of Che Guevara” to a professional and regulated industry, Ms. Titus said she was impressed by CannLab’s and their commitment to bringing “high standards of quality and safety to the medical cannabis industry”. She went on to suggest that her colleagues in Congress should visit facilities like these to understand the change.

CannLabs provides cannabis testing and business intelligence services to customers in states that have legalized medical or adult-use cannabis through its relationship with Carbon Bond Holdings Inc. and a number of state certified labs. Last quarter, the company announced the licensing approval of an 8,000 square foot facility in Nevada and the opening of a 4,000 square foot facility in Connecticut.

During the quarter, the company also reported $474,000 in revenue, which is a substantial increase over the comparable period’s $204,000 in revenue. Management attributed the growth to increased testing volumes, growing client demand, and expansions in mandated testing requirements. Revenue for its Colorado facility is expected to be $3-5 million annually by the end of 2015.

For more information about CannLabs Inc., visit their website at or coverage of the company at

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: